Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02343549
What this trial is testing

A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

Who this might be right for
Cancer of Brain and Nervous System
Wake Forest University Health Sciences 13
Early research (Phase 1)Ended earlyNCT03107780
What this trial is testing

Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

Who this might be right for
GlioblastomaGliosarcomaMGMT-Unmethylated Glioblastoma+1 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT03050736
What this trial is testing

Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression

Who this might be right for
GliomaGlioblastomaGlioblastoma Multiforme+2 more
Kintara Therapeutics, Inc. 29
Testing effectiveness (Phase 2)Looking for participantsNCT06504381
What this trial is testing

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Who this might be right for
High Grade GliomaMGMT-Unmethylated GlioblastomaMGMT-Methylated Glioblastoma
University of California, San Francisco 70
Early research (Phase 1)Active Not RecruitingNCT05450744
What this trial is testing

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)

Who this might be right for
Neoplastic DiseaseGlioblastomaGlioblastoma Multiforme
Telix Pharmaceuticals (Innovations) Pty Limited 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03395587
What this trial is testing

Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Heinrich-Heine University, Duesseldorf 136
Testing effectiveness (Phase 2)UnknownNCT04840069
What this trial is testing

Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed Glioblastoma
St. Joseph's Hospital and Medical Center, Phoenix 100
Large-scale testing (Phase 3)Study completedNCT00884741
What this trial is testing

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaSupratentorial Glioblastoma
National Cancer Institute (NCI) 637
Early research (Phase 1)Study completedNCT00095771
What this trial is testing

Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Testing effectiveness (Phase 2)Study completedNCT01209442
What this trial is testing

Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Colorado, Denver 30
Early research (Phase 1)Looking for participantsNCT07134842
What this trial is testing

A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.

Who this might be right for
GlioblastomaGliosarcoma, AdultGlioblastoma - Category
University College, London 16
Early research (Phase 1)Study completedNCT00584883
What this trial is testing

A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain Tumor
University of Alabama at Birmingham 24
Early research (Phase 1)Study completedNCT02903069
What this trial is testing

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Who this might be right for
GlioblastomaMalignant Glioma
Celgene 66
Not applicableStudy completedNCT00499798
What this trial is testing

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility
Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Study completedNCT03139916
What this trial is testing

Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Massachusetts General Hospital 36
Testing effectiveness (Phase 2)Study completedNCT00687765
What this trial is testing

Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma
Sanofi 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT01985087
What this trial is testing

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

Who this might be right for
Glioblastoma
University of Louisville 18
Early research (Phase 1)Study completedNCT02189109
What this trial is testing

The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma

Who this might be right for
Glioblastoma Multiforme
NuvOx LLC 11
Early research (Phase 1)Study completedNCT00385853
What this trial is testing

PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs

Who this might be right for
Glioblastoma
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Looking for participantsNCT06649851
What this trial is testing

G-CSF After Chemo-radiation in Patients With Glioblastoma

Who this might be right for
MGMT-Methylated GlioblastomaGlioblastoma (GBM)Newly Diagnosed Glioblastoma Multiforme
Massachusetts General Hospital 60
Next Page